IIP Q3 2026 Earnings: AFFO per Share Climbs 15%

Innovative Industrial Properties (IIP, NYSE: IIPR) reported Q3 2026 revenue of $64.9 million, up 0.4% from $64.7 million a year earlier, while diluted EPS rose to $0.99 from $0.97. For the quarter ended September 30, AFFO increased to $54.8 million, or $1.96 per share, as investment income helped offset flat operating profit and continued disruption among several cannabis tenants.

Core Earnings Data

Property operations were broadly stable. Lower property expenses were offset by higher depreciation and amortization and a $0.6 million real estate impairment, leaving operating income essentially unchanged at $29.4 million.

The modest revenue increase reflected security deposits applied to repossessed properties, partly offset by lower rent following property sales and lease terminations. Non-GAAP REIT measures improved more substantially than GAAP earnings, with AFFO per share rising 14.6% year over year.

FFO, Normalized FFO, and AFFO are non-GAAP measures used to assess REIT operating performance and are attributable to common stockholders.

Portfolio and Investment Activity

Life Science Deployments

IIP expanded its life science exposure during the quarter. It entered into a $245 million mezzanine loan commitment connected with Alewife Park in Cambridge, Massachusetts, funding approximately $111 million at closing. The remaining $134 million is expected to be funded through the fourth quarter of 2027, subject to funding conditions.

The loan has an expected interest rate of approximately 15.8% over its term, subject to a 14% floor, and matures in February 2028 with a one-year extension option. IIP also has an option, subject to conditions, to acquire up to another $155 million of mezzanine notes on the same terms.

Separately, IIP funded $30 million of IQHQ Series G preferred equity. Its funded strategic investment in IQHQ reached $300 million at quarter-end, consisting of a $100 million revolving credit facility and $200 million of preferred equity. Life science investments on the balance sheet increased to $417.4 million from $152.7 million at the end of 2025.

Cannabis Leasing and Tenant Remediation

Portfolio turnover remained substantial. IIP terminated 16 leases covering 1.2 million square feet during the quarter and entered into six leases covering 604,000 square feet. After quarter-end, it signed a lease for a 270,000-square-foot property in Saxton, Pennsylvania, but effectiveness remains contingent on cannabis license transfer approvals.

IIP had terminated all PharmaCann leases by September 30 and regained possession of two Parallel properties and seven properties previously leased to Cannabist. Three properties still leased to 4Front represented 7.1% of annualized contractual rent. Tentative replacement arrangements for those assets remain subject to licensing, receivership, and other contingencies.

Payments and applied security deposits from five defaulted tenants totaled $11.6 million, or $0.41 per share, compared with $10.5 million, or $0.35 per share, in Q2 2026. Of the Q3 total, $3.8 million came from security deposits applied to Cannabist and Parallel properties.

Life Science Income Offset Flat Property Operations

The quarter’s earnings mix changed more than the reported revenue growth suggests. Interest and other income, which is reported below operating income rather than in total revenue, rose to $14.3 million from $4.4 million. This included $10.4 million of interest and dividend income associated with IQHQ investments, along with interest on seller financing for the Perth, New York property sale.

Higher financing costs absorbed much of that increase. Interest expense rose to $11.8 million from $4.5 million, while preferred stock dividends increased to $3.2 million from $1.0 million. As a result, common-stockholder net income grew only 1.5% even though Normalized FFO and AFFO increased at double-digit rates. The AFFO improvement also reflects the measure’s defined adjustments and should not be treated as equivalent to recurring rental growth.

Balance Sheet, Financing, and Dividend

IIP ended the quarter with $142.4 million of liquidity, consisting entirely of cash and cash equivalents, up from $47.6 million at the end of 2025. Net debt equaled 18.7% of $3.0 billion in gross assets, and net debt to Adjusted EBITDA was 2.1 times.

Total liabilities increased to $820.2 million from $522.9 million at year-end as exchangeable notes and term loans were added and revolving credit balances increased. After quarter-end, IIP raised $54.2 million in gross proceeds through an offering of 9.25% Series B preferred stock. It also extended an $87.5 million revolving credit facility by 90 days to January 21, 2027.

The quarterly common dividend was $1.90 per share, equivalent to an annualized $7.60. That represented approximately 97% of Q3 AFFO per share. AFFO is not the same as operating cash flow or cash available for distributions, so future dividend coverage also depends on financing costs, investment funding, and tenant collections.

Recent Insider Transactions

The six-month summary showed 34,698 shares acquired and 611 sold, resulting in a net acquisition of 34,087 shares across five reported transactions. Because those totals include zero-price stock awards, they should not be interpreted as entirely open-market buying; the two transactions with clear market terms were as follows.

Other recent entries included zero-price stock awards to CEO Paul Smithers, CFO David Smith, director Bruce Ives, and officer Andy Bui. The supplied records did not state the share quantities for those individual grants.

Risks Investors Should Monitor

• Tenant defaults and contingent re-leasing: Lease terminations covered 1.2 million square feet, while new leases covered 604,000 square feet. Several proposed replacement leases depend on license transfers, receivership proceedings, or other approvals.
• Reliance on deposits and non-rental income: Applied security deposits and payments from defaulted tenants supported quarterly results but can vary by period and do not by themselves establish restored recurring rent.
• IQHQ exposure and future funding: IQHQ-related income was a major earnings contributor, while IIP still expects to fund another $134 million under the Alewife Park commitment subject to conditions. Counterparty performance and funding timing can affect both earnings and liquidity.
• Financing costs and dividend coverage: Interest expense and preferred dividends rose materially, and the quarterly common dividend was close to AFFO per share. Additional preferred capital and a short-term credit facility extension increase the importance of monitoring funding costs and refinancing progress.

Summary

IIP’s Q3 2026 results combined nearly flat rental revenue and operating income with faster growth in AFFO, supported by expanding life science investment income and non-GAAP adjustments. The central issues ahead are whether cannabis property re-leasing converts contingent arrangements into recurring rent, whether IQHQ investments continue producing income as planned, and how rising financing obligations affect dividend coverage and liquidity.